In this volume, we explore promising developments in psychiatric treatments, including a new drug (KarXT) for schizophrenia and an antipsychotic (iloperidone) for bipolar mania. This volume also investigates the use of machine learning to predict psychosis conversion, the differentiation between substance-induced psychosis and schizophrenia, and ways to reduce racial bias in physical restraint use in emergency rooms. Do we have an unconscious bias when making decisions about using restraints?
- Provider:Medical Academy, LLC
- Activity Link: https://psychopharmacologyinstitute.com/publication/quick-take-vol-63-2802?utm_source=PARS+ACCME&utm_medium=PARS+ACCME&utm_campaign=PARS+ACCME
- Start Date: 2024-06-01 05:00:00
- End Date: 2024-06-01 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 0.75 hours
- Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Yes
- Measured Outcome: Learner Performance
- Provider Ship: Jointly Provided
- Registration: Limited
Subscribe
Login
0 Comments
Oldest